Two Sigma Investments’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
Other funds holding GPCR
BBA
Two Sigma Investments's GPCR Position: Q3 2026 in Review
Two Sigma Investments increased its Structure Therapeutics (GPCR) stake by 117% in Q3 2026, buying an estimated $11.2M and bringing the position to 442,107 shares worth $13.8M. The position accounts for 0.01% of the portfolio, ranked #1290.
Two Sigma Investments first reported a position in GPCR in Q3 2025 and has held it in 5 quarters since. 172 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.
- Two Sigma Investments held 442,107 shares of Structure Therapeutics worth $13.8M as of Q3 2026.
- Two Sigma Investments bought 237,951 Structure Therapeutics shares in Q3 2026, an estimated $11.2M.
- Structure Therapeutics made up 0.01% of Two Sigma Investments's portfolio in Q3 2026, its #1290 holding.
- Two Sigma Investments first reported a position in Structure Therapeutics in Q3 2025 and has held it in 5 quarters since.
- 172 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.